Singapore markets open in 29 minutes
Straits Times Index
3,326.28 +12.14 (+0.37%) S&P 500
5,469.30 +21.43 (+0.39%) Dow
39,112.16 -299.05 (-0.76%) Nasdaq
17,717.65 +220.84 (+1.26%) Bitcoin USD
61,808.96 +1,483.77 (+2.46%) CMC Crypto 200
1,280.78 +31.66 (+2.53%)
UTHR241115P00320000
. Currency in USD
Add to watchlist
| Previous close | N/A |
| Open | N/A |
| Bid | N/A |
| Ask | N/A |
| Strike | N/A |
| Expiry date | N/A |
| Day's range | N/A - N/A |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GuruFocus.comInsider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
United Therapeutics Corp, a biotechnology firm, focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Over the past year, Christopher Causey has engaged in multiple transactions, selling a total of 12,640 shares and purchasing none. Shares of United Therapeutics Corp were priced at $304.18 on the day of the sale.
GuruFocus.comInsider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
Director Judy Olian sold 1,700 shares of United Therapeutics Corp (NASDAQ:UTHR) on June 17, 2024, as reported in a recent SEC Filing.
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
© 2024 Yahoo. All rights reserved.